Clinical trials
Hypertension, Pulmonary trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 7 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| No longer available | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 12 |
| GlaxoSmithKline | 5 |
| Pfizer | 3 |
| Biogen | 2 |
| Eli Lilly and Company | 2 |
| Insmed Incorporated | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Association for Pediatric Pulmonary Hypertension | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 36 |
| Pulmonary Arterial Hypertension | 17 |
| Lung Diseases, Interstitial | 3 |
| Ventricular Dysfunction, Left | 2 |
| Cardiovascular Diseases | 1 |
| Congenital Portosystemic Shunt | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Fibrosis | 1 |
| Heart Failure | 1 |
| Hepatic Encephalopathy | 1 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.